Chancre Definition & Clinical Guide: Diagnosis, Treatment, Prevention

Why understanding chancre matters and common misconceptions

A chancre is the hallmark lesion of primary syphilis and often the first clinical clue. A chancre most commonly appears about three weeks after exposure (median ~21 days; range 10–90 days) and typically presents as a single painless ulcer. Clinicians frequently misidentify chancres as trauma, herpes, or chancroid, which delays therapy (StatPearls). Up to 30% of primary syphilis cases are initially misdiagnosed, increasing transmission risk.

For related resources, see the Rounds AI clinical reference platform and the Secondary syphilis guide.

According to CDC 2023 STD Surveillance, primary and secondary syphilis increased year‑over‑year. Rounds AI provides concise, citation‑linked answers synthesized from current clinical guidelines, peer‑reviewed research, and FDA prescribing information. It’s available on web and iOS, with a 3‑day free trial so clinicians can evaluate it at the point of care. Clinicians can use Rounds AI to surface the latest CDC‑cited guidance at the point of care. Accurate recognition reduces treatment delays and helps interrupt transmission at both patient and population levels. This guide covers definition, typical appearance, differential diagnosis, diagnostic testing, treatment, and prevention strategies. Learn more about Rounds AI's approach to evidence-linked clinical Q&A as you read on.

Chancre: definition and clinical presentation

Typical appearance

A chancre is the classic lesion of primary syphilis: a solitary, painless, indurated ulcer that marks initial Treponema pallidum infection. Start with timeline and exposure history—note the date of possible exposure, recent sexual contacts, condom use, and any systemic symptoms. It most commonly appears about three weeks after exposure, with a median incubation around 21 days (range 10–90 days) (CDC STD Treatment Guidelines). The lesion typically heals on its own within 3–6 weeks if untreated, even as infection progresses systemically (NCBI Bookshelf).

Common sites

Typical anatomical sites include the external genitalia, vagina, anus, oral mucosa, or other extragenital skin where inoculation occurred (NCBI Bookshelf). Chancre size usually ranges from about 0.5 to 2 cm in diameter. The base is generally clean and the edges are raised and firm—features that help distinguish it from other ulcers (Mayo Clinic).

Differential diagnosis

Differentiation matters at the point of care. Herpes simplex typically causes multiple, painful vesicles or ulcers. Chancroid presents as painful, often multiple, soft ulcers with ragged edges. The chancre’s solitary, painless, indurated appearance is the key distinguishing clue in most cases (CDC STD Treatment Guidelines).

• Definition: solitary, painless, indurated ulcer (primary syphilis).
• Typical timeline: median incubation ~21 days (range 10–90 days); lesion lasts 3–6 weeks.
• Common sites: genitalia, anus, oral mucosa, extragenital skin.
• Appearance: 0.5–2 cm, clean base, raised firm edges.
• Key differentials: herpes simplex (painful), chancroid (painful, multiple).

Primary chancres remain a common first presentation worldwide. The World Health Organization reported millions of new syphilis cases globally, with primary-stage lesions often representing initial clinical disease (WHO). For clinicians managing suspected chancres, concise, evidence-linked summaries and source-forward references can speed verification at the bedside. Rounds AI offers citation-centered clinical answers that help clinicians confirm diagnostic features and relevant guidance quickly. Learn more about Rounds AI’s approach to evidence-linked point-of-care reference to support diagnostic clarity in your practice.

Key components and diagnostic criteria for chancre

A clear diagnostic approach to a chancre rests on three core elements: a compatible exposure history, the characteristic lesion, and laboratory confirmation. These components guide bedside decision making and help determine when direct detection methods are needed. Clinicians using Rounds AI can rapidly review these diagnostic checkpoints tied to guideline and laboratory evidence while at the point of care.

• Exposure history within prior ~3 months (focused sexual history).
• Physical finding: typically a single painless ulcer with a clean base and firm edges.
• Initial testing: non-treponemal test (RPR or VDRL).
• Confirmatory testing: treponemal test (TP-PA, FTA-ABS, or equivalent).
• Direct detection (dark-field microscopy or PCR) when serology is negative and clinical suspicion is high.

Start with timeline and exposure. The average incubation period is about 21 days, with a range of 10–90 days, so a focused sexual history within three months is informative (CDC MMWR). The chancre commonly appears about three weeks after exposure and may heal in 3–6 weeks without treatment (CDC Laboratory Recommendations).

Next confirm the lesion. A classic chancre is usually a single, painless ulcer with a clean base and firm, indurated margins. Lesion location may be genital, oral, or perianal, so exam should be targeted and thorough (CDC MMWR).

Laboratory strategy pairs a non-treponemal screening test with a treponemal confirmatory test. In very early primary syphilis, serologic tests can be nonreactive; sensitivity increases over the first few weeks. If initial serology is negative but suspicion remains high, repeat in 1–2 weeks or use direct detection (dark-field microscopy or PCR) per CDC algorithms (CDC Laboratory Recommendations). Rounds AI helps clinicians recall these timing nuances with citations to CDC laboratory recommendations.

Rounds AI’s evidence-linked answers can help clinicians recall these timing and testing nuances during evaluation. For complex or equivocal cases, combining careful exposure assessment, focused examination, and the recommended laboratory sequence ensures the most reliable chancre diagnosis.

How a chancre develops and how to diagnose primary syphilis

Primary infection begins when Treponema pallidum enters skin or mucosa at the exposure site. The organism replicates locally, and a painless, firm ulcer (chancre) typically appears about 21 days later (CDC MMWR). Lesions often persist 3–6 weeks if untreated, while systemic serology may lag behind the lesion.

At the bedside, use a concise, evidence-based diagnostic workflow drawn from CDC guidance (CDC STD Treatment Guidelines).

1. Take a focused sexual exposure history (last 90 days).

2. Perform a targeted skin/genital exam; document ulcer size, number, induration, and pain (characteristics described in surveillance guidance CDC MMWR).

3. Order a non-treponemal test (RPR or VDRL); if negative but suspicion is high, repeat in 1 week (early RPR sensitivity is limited; follow CDC testing algorithms (CDC STD Treatment Guidelines)).

4. If serology is negative and the lesion is ≤7 days or clinical suspicion remains high, perform dark-field microscopy or PCR of lesion exudate (direct detection methods are recommended in laboratory guidance (CDC Laboratory Recommendations; see practical notes on point-of-care microscopy MLO Online)).

5. Confirm positive serology with a treponemal test (FTA‑ABS, TP‑PA) and document findings per public-health reporting rules; clinicians using evidence-linked tools like Rounds AI can quickly surface the exact guideline citations to support documentation and management decisions.

Document exam findings and test dates in the record, and follow local reporting requirements. For quick, verifiable references to the CDC testing algorithm and laboratory options, Rounds AI helps surface guideline and laboratory citations at the point of care, supporting timely, defensible decisions.

Treatment options for chancre and follow‑up care

Early treatment of a chancre (primary syphilis) follows established guideline regimens and routine serologic monitoring. The U.S. Centers for Disease Control and Prevention recommends a single intramuscular dose of benzathine penicillin G, 2.4 million units, as first‑line therapy for primary syphilis (CDC STD Treatment Guidelines). For patients with penicillin allergy, doxycycline 100 mg orally twice daily for 14 days is the commonly recommended alternative (CDC STD Treatment Guidelines; see additional context at the Mayo Clinic).

• First-line: benzathine penicillin G 2.4 million units intramuscular single dose (CDC 2024).
• Penicillin allergy alternative: doxycycline 100 mg orally twice daily for 14 days (CDC recommended alternative).
• Follow-up: repeat non-treponemal serology at 6 and 12 months; expect ≥4-fold decline in titers for successful treatment.
• Outcomes and caveats: >95% serologic cure with benzathine penicillin; regional protocols (e.g., two-dose approaches) may vary.

Follow-up serologic testing uses non‑treponemal assays (RPR or VDRL). Repeat testing at about 6 months and 12 months post‑treatment documents response. A ≥4‑fold decline in titer (for example, 1:32 to 1:8) usually indicates serologic cure; failure to decline suggests treatment failure or reinfection and warrants re-evaluation (CDC STD Treatment Guidelines). The World Health Organization reports high cure rates with appropriate penicillin therapy, noting cure in over 95% of early syphilis cases when treated (WHO syphilis fact sheet).

Some national guidelines recommend variations. For example, Canadian guidance allows two weekly doses of benzathine penicillin G in certain early‑stage protocols, reflecting regional practice differences and emerging data (Canadian Guidelines).

Public‑health steps matter. Notify and test recent sexual partners, and follow local reporting rules to support contact tracing and control. For clinicians and clinical leaders seeking rapid, evidence‑linked references at the point of care, Rounds AI surfaces guideline‑grounded answers clinicians can verify quickly. Learn more about Rounds AI’s approach to concise, cited clinical answers for infectious‑disease questions and follow‑up workflows.

Recognize a painless, indurated chancre as likely primary syphilis and act promptly. Confirm with appropriate testing and interpret results alongside clinical findings per the CDC STD Treatment Guidelines – Syphilis. Treat according to current recommendations; penicillin-based therapy remains first-line for early disease.

Arrange follow-up serology and clinical reassessment, and ensure partner notification plus public-health reporting per national surveillance guidance (Primary Syphilis Overview). These steps protect patients and guide community control efforts.

For CMOs and clinical leaders, prioritize evidence-linked, citation-forward resources that support bedside verification and institutional policy. Rounds AI is built with a privacy‑first, HIPAA‑aware architecture, and enterprise customers can obtain a Business Associate Agreement (BAA), supporting use in regulated health‑system environments. Rounds AI provides concise, citation-linked answers clinicians can check before acting. Learn more about Rounds AI's approach to evidence-linked clinical answers to support point-of-care confidence and dependable documentation.